ArticleFrontiers in oncology2021

Case Report: High-Level MET Amplification as a Resistance Mechanism of ROS1-Tyrosine Kinase Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer.

Jiangping Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.